Interior picture of Canal St. lab

Nathaniel (Nate) Hafer

Nate Hafer is the Director of Operations for the University of Massachusetts Center for Clinical and Translational Science (UMCCTS) and an Assistant Professor in the Program in Molecular Medicine, UMass Medical School.
Nathaniel (Nate) HaferDirector - M2D2; Director of Operations, UMass Center for Clinical & Translational Science - University of Massachusetts Medical School, Worcester; Assistant Professor in the Program in Molecular Medicine, UMass Medical School

Biography

Nate Hafer is the Director of Operations for the University of Massachusetts Center for Clinical and Translational Science (UMCCTS) and an Assistant Professor in the Program in Molecular Medicine, UMass Medical School. The UMCCTS is based at the UMass Medical School in Worcester and is part of the NIH Clinical and Translational Science Award (CTSA) consortium. The goals of the center are to:

  1. accelerate clinical and translational research in order to improve the health of patients and communities, and
  2. educate the next generation of clinical and translational researchers. Hafer, Ph.D., coordinates overall activities and assists in the implementation of sponsored programs associated with the UMCCTS. In this role he serves as a contact person to extramural resources (biotech/ pharma, NIH, other academic centers), describes resource opportunities to researchers, aids investigators in project development, and maintains a working knowledge of all UMCCTS services, programs, operations, and personnel. In addition he directs all UMCCTS pilot funding programs and I-Corps educational programming at UMMS. Previously, Hafer was an American Association for the Advancement of Science (AAAS) Science and Technology Policy Fellow at the National Institute for Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). Before joining NIH, Dr. Hafer worked at the Federation of American Scientists and was a Science and Technology Policy Graduate Fellow at the National Academies. He completed his Ph.D. in molecular biology at Princeton University and received a BS in biology from Penn State with a minor in science, technology, and society.